MAPT and Alzheimer disease: The specificity of the ligand was evaluated by staining AD hippocampal samples which showed that, consistent with previous studies [27], bTVBT2 binds to aggregated tau pathologies such as NTs and NFTs, but it is most pronounced in dystrophic neurites.